Okay, let's tackle this question about why Clopidogrel is preferred over Ticlodipine. First, I need to recall what both drugs do. Clopidogrel is an antiplatelet agent, right? It's a P2Y12 receptor antagonist, inhibiting ADP-mediated platelet activation. Ticlodipine is another antiplatelet drug, but I think it's less commonly used now.

The core concept here is comparing these two drugs in terms of their efficacy, safety, and side effects. The question is asking why one would be preferred over the other. I remember that Ticlodipine had some significant side effects, like causing a higher incidence of neutropenia and liver toxicity. That might be a key point. Clopidogrel, on the other hand, has a better safety profile and maybe a faster onset.

Now, the correct answer is likely related to Ticlodipine's adverse effects. Let me check the options again. The options aren't listed, but the correct answer is supposed to be the reason for preference. So, Clopidogrel's advantages would include fewer side effects, better tolerability, and maybe more predictable dosing. Ticlodipine requires monitoring for neutropenia and liver enzymes, which would make it less favorable.

For the incorrect options, I need to think of possible distractors. They might include things like better efficacy, lower cost, or different mechanisms. But the real reason is the safety profile. So the wrong options would be incorrect because they don't address the main issue of adverse effects. For example, if an option says "lower cost," that's not the main reason. Or if it mentions "faster onset," maybe that's true but not the primary reason for preference.

The clinical pearl here is to remember that Ticlodipine is associated with significant hematological and hepatic side effects, making Clopidogrel the preferred choice. Students should note that Ticlodipine is rarely used now due to these risks.

**Core Concept**
This question compares **clopidogrel** and **ticlopidine**, two **P2Y12 ADP receptor antagonists** used for antiplatelet therapy. The key distinction lies in their **safety profiles**, as ticlopidine is associated with severe side effects, whereas clopidogrel has a better tolerability profile.

**Why the Correct Answer is Right**
Clopidogrel is preferred over ticlopidine because it has a **lower risk of neutropenia** and **hepatotoxicity**, which are common with ticlopidine. Ticlopidine inhibits **myeloid cell function**, leading to agranulocytosis in ~1% of patients, requiring regular blood monitoring. Clopidogrel, while also a thienopyridine, has a **reduced incidence of these hematologic adverse effects**, making it safer and more practical for long-term use. Both drugs inhibit platelet aggregation via ADP receptor blockade, but clopidogrel’s improved safety profile makes it the first-line choice.

**Why Each Wrong Option is Incorrect**
**Option A:** *“Lower cost of ticlopidine”* is incorrect. Ticlopidine is not cost-effective due to its side effects, and clopidogrel is widely available and affordable.
**Option B:** *“Faster onset

✓ Correct Answer: C. Side effect